Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth R Volkmann

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
JAMA Network Open|December 14, 2020
The Association of Autoimmune Disease With Lung Cancer SurvivalElizabeth R Volkmann
Annals of Family Medicine|April 5, 2017
Silent SurvivorsElizabeth R Volkmann
The Lancet. Rheumatology|August 2, 2021
Molecular imaging for systemic sclerosis-interstitial lung diseaseElizabeth R Volkmann
The European Respiratory Journal|June 8, 2023
Combining rituximab with mycophenolate for the treatment of interstitial lung diseaseElizabeth R Volkmann
Expert Review of Clinical Immunology|December 28, 2022
Is there a role for the microbiome in systemic sclerosis?Elizabeth R Volkmann
Lancet (London, England)|July 27, 2020
Tapering glucocorticoids in rheumatoid arthritisElizabeth R Volkmann
Arthritis & Rheumatology (Hoboken, N.J.)|November 4, 2024
Understanding Late-Onset Interstitial Lung Disease in Systemic Sclerosis: Implications for Clinical Practice and Trial DesignElizabeth R Volkmann
Journal of Scleroderma and Related Disorders|March 11, 2021
Natural History of Systemic Sclerosis-Related Interstitial Lung Disease: How to Identify a Progressive Fibrosing PhenotypeElizabeth R Volkmann
Chest|April 9, 2022
Occupational Exposures and Systemic Sclerosis-Related Lung DiseaseElizabeth R Volkmann
Current Opinion in Rheumatology|July 19, 2017
Intestinal microbiome in scleroderma: recent progressElizabeth R Volkmann
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
JAMA Network Open|December 14, 2020
The Association of Autoimmune Disease With Lung Cancer SurvivalElizabeth R Volkmann
Annals of Family Medicine|April 5, 2017
Silent SurvivorsElizabeth R Volkmann
The Lancet. Rheumatology|August 2, 2021
Molecular imaging for systemic sclerosis-interstitial lung diseaseElizabeth R Volkmann
The European Respiratory Journal|June 8, 2023
Combining rituximab with mycophenolate for the treatment of interstitial lung diseaseElizabeth R Volkmann
Expert Review of Clinical Immunology|December 28, 2022
Is there a role for the microbiome in systemic sclerosis?Elizabeth R Volkmann
Lancet (London, England)|July 27, 2020
Tapering glucocorticoids in rheumatoid arthritisElizabeth R Volkmann
Arthritis & Rheumatology (Hoboken, N.J.)|November 4, 2024
Understanding Late-Onset Interstitial Lung Disease in Systemic Sclerosis: Implications for Clinical Practice and Trial DesignElizabeth R Volkmann
Journal of Scleroderma and Related Disorders|March 11, 2021
Natural History of Systemic Sclerosis-Related Interstitial Lung Disease: How to Identify a Progressive Fibrosing PhenotypeElizabeth R Volkmann
Chest|April 9, 2022
Occupational Exposures and Systemic Sclerosis-Related Lung DiseaseElizabeth R Volkmann
Current Opinion in Rheumatology|July 19, 2017
Intestinal microbiome in scleroderma: recent progressElizabeth R Volkmann
Pageof 15